Sign In   Register

Cannabis and Hemp Industry Investment News

Cannabis Industry Press Releases and News Articles from the best investment journalist in the industry. Stay updated on all cannabis investment news from every online source, on MjInvest.com

1933 Industries taps CB1 Capital Advisors as consultant

What are you searching for? view1933 Industries Inc. CB1 Capital will help 1933 analyze investments and partnerships Based in Vancouver, 1933 speciali...

Chemistree granted conditional use permit for Desert Hot Springs land

Chemistree expects its Desert Hot Springs facility could produce about 50,000 pounds of dried-cannabis flower per year Vancouver-based Chemistree is a...

FSD Pharma wins standard processing license

What are you searching for? viewFSD Pharma The processing license will bring FSD's subsidiary FV Pharma Inc a step closer to securing a sales license ...

Biome Grow sends first shipment of finished product to Newfoundland and Labrador

What are you searching for? viewBiome Grow, Inc. Biome Grow () CEO Khurram Malik joined Steve Darling from Proactive Investors Vancouver on Skype from...

FSD Pharma CFO bolsters World Class Extractions team

What are you searching for? viewFSD Pharma It was announced FSD Pharma CFO Donal Carroll will join the board of directors or management of World Class...

Harvest One Cannabis inks validation testing agreement with BLOCKStrain Technology

Harvest One will use BLOCKStrain's proprietary genome tracking software to collect and register cannabis plant DNA and strains Harvest One develops an...

Medlab Clinical expands depression trial recruitment, shares open 5% higher

New research corroborates the company’s direction of studying the use of NRGBiotic™ to improve gut health. Globally, more than 300 million people suff...

1933 Industries steps up its CBD consumer product distribution in US

The company said owning its distribution is 'key’ to its growth strategy ensuring that its branding and messaging is ‘properly delivered’ Infused MFG’...

Canntab sign supply agreement with FSD Pharma and World Class Extractions

Canntab Therapeutics () Chief Financial Officer Richard Goldstein sat down with Steve Darling from Proactive Investors Vancouver to discuss the news t...

CannPal Animal Therapeutics receives approvals for two clinical studies

CPAT-01 is CP1’s lead pharmaceutical product and is derived from cannabinoids. CPAT-01’s market is estimated to be worth US$1 billion globally () has ...

CannPal Animal Therapeutics chairman buys company shares

What are you searching for? viewCannPal Animal Therapeutics Ltd 80,000 shares at a cost of $10,193 represents a 12.7 cents per share average cost pric...

Biome Grow announces pact with CBD Acres for CBD extract

This arrangement provides certainty of supply for Biome as well as assurance of a market-best price for its customers Rapidly growing marijuana group ...

High Hampton sets goal of becoming California brands leader in 2019

The company says it will own and operate the processes that allow it to manufacture, infuse and package recreational and wellness products Last month,...

FSD Pharma and Canntab Therapeutics forge pact with World Class Extractions to strike hemp deal

The trio of companies are also in the process of striking a second agreement to purchase Thomas Elcome's 2019 hemp crop Inc, the licensed Canadian can...

AusCann Group on track to produce cannabinoid medicines this year

() (OTCQX:ACNNF) aims to produce high-quality, economical, and clinically-validated cannabinoid medicines. It has a vertically integrated strategy beg...


MjInvest.com